Evotec Enters into Long-Term Focused Library Agreement with Almirall
Value Exceeding EUR 2.5 m over the Two-Year Contract Period
26-Jul-2005
Evotec AG and Almirall Prodesfarma S.A., the leading Spanish multinational company, announced that they have entered into a two-year library synthesis agreement.
Applying leading skills in high-speed parallel synthesis, medicinal and com-putational chemistry Evotec will design and synthesise for Almirall several thousand drug-like compounds across a wide range of chemical templates. With Evotec's state-of-the-art integrated autopurification and analytical plat-forms each compound will be of the highest purity to deliver high quality results in Almirall's pharmaceutical screening and medicinal chemistry pro-grammes.
Other news from the department business & finance
